Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 16, 2022

BUY
$53.92 - $71.7 $237,571 - $315,910
4,406 New
4,406 $246,000
Q2 2022

Aug 15, 2022

SELL
$38.49 - $76.21 $206,883 - $409,628
-5,375 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$58.27 - $118.99 $2,971 - $6,068
-51 Reduced 0.94%
5,375 $390,000
Q4 2021

Feb 15, 2022

SELL
$100.76 - $138.36 $52,193 - $71,670
-518 Reduced 8.71%
5,426 $641,000
Q3 2021

Nov 15, 2021

SELL
$132.37 - $176.78 $59,831 - $79,904
-452 Reduced 7.07%
5,944 $797,000
Q2 2021

Aug 16, 2021

SELL
$60.88 - $161.91 $133,266 - $354,420
-2,189 Reduced 25.5%
6,396 $1.03 Million
Q1 2021

May 18, 2021

SELL
$46.59 - $83.68 $13,184 - $23,681
-283 Reduced 3.19%
8,585 $688,000
Q3 2020

Nov 16, 2020

SELL
$17.47 - $24.93 $53,772 - $76,734
-3,078 Reduced 25.77%
8,868 $175,000
Q2 2020

Aug 14, 2020

BUY
$11.14 - $22.87 $49,004 - $100,605
4,399 Added 58.29%
11,946 $249,000
Q4 2019

Feb 12, 2020

BUY
$10.43 - $17.67 $43,806 - $74,214
4,200 Added 125.49%
7,547 $109,000
Q3 2019

Nov 14, 2019

BUY
$13.07 - $18.51 $7,802 - $11,050
597 Added 21.71%
3,347 $43,000
Q4 2018

Feb 14, 2019

BUY
$11.39 - $27.13 $31,322 - $74,607
2,750 New
2,750 $37,000
Q3 2018

Nov 15, 2018

SELL
$25.78 - $32.6 $79,918 - $101,060
-3,100 Closed
0 $0
Q2 2018

Aug 15, 2018

BUY
$20.02 - $30.79 $62,062 - $95,449
3,100 New
3,100 $85,000

Others Institutions Holding NTLA

About Intellia Therapeutics, Inc.


  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $929M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Glenmede Trust CO Na Portfolio

Follow Glenmede Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.